Empirical Finance LLC Buys 385 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Empirical Finance LLC lifted its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 2.9% in the 3rd quarter, Holdings Channel reports. The fund owned 13,480 shares of the company’s stock after acquiring an additional 385 shares during the quarter. Empirical Finance LLC’s holdings in GE HealthCare Technologies were worth $1,265,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in GEHC. CIBC Asset Management Inc lifted its holdings in shares of GE HealthCare Technologies by 8.4% in the third quarter. CIBC Asset Management Inc now owns 141,209 shares of the company’s stock valued at $13,252,000 after purchasing an additional 10,974 shares in the last quarter. OneDigital Investment Advisors LLC raised its position in GE HealthCare Technologies by 7.5% in the 3rd quarter. OneDigital Investment Advisors LLC now owns 13,798 shares of the company’s stock valued at $1,295,000 after buying an additional 961 shares during the last quarter. ING Groep NV bought a new stake in GE HealthCare Technologies in the 3rd quarter valued at approximately $2,973,000. Tokio Marine Asset Management Co. Ltd. boosted its position in GE HealthCare Technologies by 2.3% during the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 12,560 shares of the company’s stock worth $1,179,000 after acquiring an additional 286 shares during the last quarter. Finally, Metis Global Partners LLC raised its holdings in shares of GE HealthCare Technologies by 2.1% in the third quarter. Metis Global Partners LLC now owns 17,467 shares of the company’s stock valued at $1,639,000 after purchasing an additional 367 shares during the last quarter. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Trading Down 1.4 %

Shares of GE HealthCare Technologies stock opened at $81.76 on Friday. GE HealthCare Technologies Inc. has a 52-week low of $66.39 and a 52-week high of $94.55. The stock has a market cap of $37.35 billion, a PE ratio of 22.46, a PEG ratio of 3.02 and a beta of 1.24. The firm has a 50-day moving average of $88.70 and a 200-day moving average of $83.48. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.06 by $0.08. The firm had revenue of $4.86 billion for the quarter, compared to analyst estimates of $4.87 billion. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The business’s revenue was up .9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.99 EPS. As a group, sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.29 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were given a dividend of $0.03 per share. The ex-dividend date of this dividend was Friday, October 18th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.15%. GE HealthCare Technologies’s payout ratio is 3.30%.

Insider Transactions at GE HealthCare Technologies

In other news, CEO Roland Rott sold 3,577 shares of the business’s stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total value of $309,338.96. Following the completion of the transaction, the chief executive officer now directly owns 24,298 shares in the company, valued at approximately $2,101,291.04. The trade was a 12.83 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.27% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on GEHC shares. JPMorgan Chase & Co. began coverage on shares of GE HealthCare Technologies in a report on Monday, September 9th. They set a “neutral” rating and a $90.00 target price for the company. Wells Fargo & Company lifted their target price on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a research report on Thursday, October 31st. Redburn Atlantic raised GE HealthCare Technologies to a “strong-buy” rating in a research report on Thursday, August 1st. BTIG Research raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price target on the stock in a research report on Wednesday, September 18th. Finally, Evercore ISI increased their price objective on GE HealthCare Technologies from $98.00 to $102.00 and gave the company an “outperform” rating in a report on Tuesday, October 1st. One research analyst has rated the stock with a sell rating, five have issued a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and an average price target of $94.36.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.